Defect Correction for Spiriva® Respimat®
DrugAlert Volume 909
HPS Pharmacies wish to give notice that Boehringer Ingelheim, in consultation with the Therapeutic Goods Administration (TGA), has issued a product defect correction for Spiriva® Respimat®, as follows: Spiriva Respimat Solution for Inhalation Tiotropium…
Read more